Free Trial

Masimo Q1 2023 Earnings Report

Masimo logo
$169.52 -0.48 (-0.28%)
(As of 12/20/2024 05:45 PM ET)

Masimo EPS Results

Actual EPS
$0.87
Consensus EPS
$0.83
Beat/Miss
Beat by +$0.04
One Year Ago EPS
$0.93

Masimo Revenue Results

Actual Revenue
$565.00 million
Expected Revenue
$557.87 million
Beat/Miss
Beat by +$7.13 million
YoY Revenue Growth
+85.70%

Masimo Announcement Details

Quarter
Q1 2023
Time
After Market Closes

Conference Call Resources

This Indicator called BOTH NVDA rallies (Ad)

Rarely would I label something as “the best” But in this rare instance, I believe this is THE BEST indicator for trading Nvida’s stock. Except, it’s not another tech stock like Nvidia. But rather a stock hiding in broad daylight… So, if you’d like to see what this stock is…

Click this link here. 

Masimo Earnings Headlines

Those who invested in Masimo (NASDAQ:MASI) a year ago are up 50%
70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today!
Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.
Masimo price target raised to $210 from $180 at Piper Sandler
Wells Fargo Keeps Their Buy Rating on Masimo (MASI)
Masimo (NASDAQ:MASI) Sets New 1-Year High After Analyst Upgrade
See More Masimo Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Masimo? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Masimo and other key companies, straight to your email.

About Masimo

Masimo (NASDAQ:MASI) develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

View Masimo Profile

More Earnings Resources from MarketBeat

Upcoming Earnings